[智利使用ICD-11进行死亡编码:主要结果和实施前景Codificação da mortalidade com a CID-11 no Chile:主要结果和实施前景]
Paulina Vera Montecinos1, Jorge Pacheco2, Sergio Guinez-Molinos3
1Servicio de Salud del Maule Talca Chile Servicio de Salud del Maule, Talca, Chile.
概括
国际疾病分类,第11次修订 (ICD-11) 显示与ICD-10有充分的一致性和可比性,表明其可用于实施. 持续培训和技术升级对于成功采用是必不可少的.
科学领域:
- 医疗信息学 医疗信息学
- 公共卫生监督 公共卫生监督
- 卫生信息系统 卫生信息系统
背景情况:
- 国际疾病分类第10版 (ICD-10) 是目前疾病分类的标准.
- 国际疾病分类,第11版 (ICD-11) 提供了增强的细节性,并为数字环境而设计.
- 评估ICD-11的可用性和与ICD-10的可比性对于其采用至关重要.
研究的目的:
- 评估ICD-11编码工具的可用性.
- 为了确定ICD-11和ICD-10之间的一致性和可比性,根据死亡原因编码.
- 评估在智利实施ICD-11的可行性.
主要方法:
- 分析了2020年2000份医疗死亡证明的样本.
- 两名专家编码员和一个黄金标准团队使用ICD-11工具编码了这些记录.
- 对死亡的直接,潜在和主要原因进行了一致性评估;章节分布进行了比较.
主要成果:
- 与临床准确性的一致性在37% (主要原因) 到76% (直接原因) 之间.
- 关于基本代码的共识范围从73% (主要原因) 到86% (直接和潜在原因).
- 科恩的卡帕表明主要原因的显著一致性 (0.68-0.76);ICD-11和映射的ICD-10分布是相似的.
结论:
- 在ICD-11和ICD-10之间存在充分的一致性和可比性.
- ICD-11工具显示出高度的可用性,支持其实施.
- 为了成功采用ICD-11,需要持续培训和技术改进.
相关概念视频
Life Tables
668
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
668
Actuarial Approach
384
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
384
Kaplan-Meier Approach
788
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
788
Applications of Life Tables
426
Life tables are versatile across various fields, providing a quantitative basis for analyzing mortality and survival rates. Whether used by demographers, actuaries, epidemiologists, or sociologists, life tables offer valuable insights into the dynamics of life and death, facilitating informed decisions in public health, insurance, conservation, and beyond. Their broad applicability highlights the interconnectedness of demographic data with practical outcomes in everyday life and strategic...
426
Cancer Survival Analysis
860
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
860
Censoring Survival Data
688
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
688


